OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
30042957

Changzhou Tronly New Electronic Materials Co Ltd

Specialty ChemicalsVerified

Changzhou Tronly's capital structure is characterized by a debt-to-equity ratio of 0.65, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 0.92, suggesting limited short-term liquidity cushion. Free cash flow is negative at -148.7 million CNY, and capital expenditures of -156.8 million CNY indicate ongoing investment in long-term assets. The company's net cash position is negative after subtracting total debt, which raises concerns about its ability to meet short-term obligations without external financing. Profitability metrics are weak, with a return on equity of -7.1% and a return on assets of -3.85%. These figures are below the typical performance of the specialty chemicals industry, which generally expects positive returns on equity and assets. The company reported a net loss of 127.3 million CNY and an operating loss of 113.1 million CNY, reflecting significant operational challenges. Gross profit of 209 million CNY is insufficient to cover operating expenses, contributing to the negative operating income. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification increases exposure to regional economic and regulatory risks. The absence of segment or geographic breakdown in the input data limits the ability to assess the company's exposure to different markets or product lines. Growth trajectory is negative, with the company reporting a revenue of 989.3 million CNY in the latest period. Analyst estimates for revenue were 776.5 million CNY, suggesting a potential overperformance in the most recent quarter. However, the company's operating and net losses indicate a lack of profitability, which could hinder long-term growth. The outlook for the current and next fiscal years is not provided in the input data, but the company's financial performance suggests a challenging path to growth. Risk factors include liquidity constraints and the potential for dilution, although the latter is assessed as low. The company's negative free cash flow and high capital expenditures increase the risk of needing to raise additional capital, which could lead to equity dilution. The risk assessment also highlights the company's negative net cash position after subtracting total debt, which could necessitate further financing. No dilution sources are explicitly cited in the input data, but the company's financial position suggests a potential need for capital raising. Recent events include the company's latest financial results, which show a net loss and negative operating income. The company's capital expenditures and free cash flow indicate ongoing investment in long-term assets, but the lack of profitability raises concerns about the sustainability of these investments. No recent filings or transcripts are provided in the input data, so the narrative is based on the latest financial snapshot.

30-day price · 300429(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyChangzhou Tronly New Electronic Materials Co Ltd
Ticker300429.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Changzhou Tronly New Electronic Materials Co Ltd is a Chinese specialty chemicals company that produces and sells electronic materials, primarily used in the semiconductor and electronics manufacturing industries.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry, with a classification confidence of 0.92.

Changzhou Tronly's capital structure is characterized by a debt-to-equity ratio of 0.65, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 0.92, suggesting limited short-term liquidity cushion. Free cash flow is negative at -148.7 million CNY, and capital expenditures of -156.8 million CNY indicate ongoing investment in long-term assets. The company's net cash position is negative after subtracting total debt, which raises concerns about its ability to meet short-term obligations without external financing. Profitability metrics are weak, with a return on equity of -7.1% and a return on assets of -3.85%. These figures are below the typical performance of the specialty chemicals industry, which generally expects positive returns on equity and assets. The company reported a net loss of 127.3 million CNY and an operating loss of 113.1 million CNY, reflecting significant operational challenges. Gross profit of 209 million CNY is insufficient to cover operating expenses, contributing to the negative operating income. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification increases exposure to regional economic and regulatory risks. The absence of segment or geographic breakdown in the input data limits the ability to assess the company's exposure to different markets or product lines. Growth trajectory is negative, with the company reporting a revenue of 989.3 million CNY in the latest period. Analyst estimates for revenue were 776.5 million CNY, suggesting a potential overperformance in the most recent quarter. However, the company's operating and net losses indicate a lack of profitability, which could hinder long-term growth. The outlook for the current and next fiscal years is not provided in the input data, but the company's financial performance suggests a challenging path to growth. Risk factors include liquidity constraints and the potential for dilution, although the latter is assessed as low. The company's negative free cash flow and high capital expenditures increase the risk of needing to raise additional capital, which could lead to equity dilution. The risk assessment also highlights the company's negative net cash position after subtracting total debt, which could necessitate further financing. No dilution sources are explicitly cited in the input data, but the company's financial position suggests a potential need for capital raising. Recent events include the company's latest financial results, which show a net loss and negative operating income. The company's capital expenditures and free cash flow indicate ongoing investment in long-term assets, but the lack of profitability raises concerns about the sustainability of these investments. No recent filings or transcripts are provided in the input data, so the narrative is based on the latest financial snapshot.
Key takeaways
  • Changzhou Tronly is a specialty chemicals company with a weak profitability profile, as evidenced by a return on equity of -7.1% and a return on assets of -3.85%.
  • The company's liquidity position is medium, with a current ratio of 0.92 and a negative free cash flow of -148.7 million CNY.
  • Revenue is concentrated in a single business segment, with no geographic diversification disclosed, increasing exposure to regional risks.
  • The company reported a net loss of 127.3 million CNY and an operating loss of 113.1 million CNY, indicating significant operational challenges.
  • The company's capital expenditures of -156.8 million CNY suggest ongoing investment in long-term assets, but the lack of profitability raises concerns about the sustainability of these investments.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$989.3M
Gross profit$209.0M
Operating income-$113.1M
Net income-$127.3M
R&D
SG&A
D&A
SBC
Operating cash flow$48.8M
CapEx-$156.8M
Free cash flow-$148.7M
Total assets$3.31B
Total liabilities$1.51B
Total equity$1.79B
Cash & equivalents
Long-term debt$1.17B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.79B
Net cash-$1.17B
Current ratio0.9
Debt/Equity0.7
ROA-3.9%
ROE-7.1%
Cash conversion-38.0%
CapEx/Revenue-15.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric300429Activity
Op margin-11.4%0.4% medp25 -8.0% · p75 16.0%bottom quartile
Net margin-12.9%2.3% medp25 -11.6% · p75 11.8%bottom quartile
Gross margin21.1%20.8% medp25 14.9% · p75 24.0%above median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-15.8%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity65.0%59.0% medp25 54.9% · p75 72.9%above median
Observations
IR observations
Last actual EPS0.18 CNY
Last actual revenue776,473,000 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-21 03:06 UTCJob: b40e8c0f